AI Chatbot for Migraine Management in Hong Kong Women
Development and Evaluation of an AI-empowered Voice-interactive Chatbot for Migraine Management Among Hong Kong Women: a Randomized Crossover Trial
2 other identifiers
interventional
49
1 country
1
Brief Summary
The goal of this randomized crossover trial is to examine whether the AI-empowered chatbot will effectively collect comprehensive migraine feature data and demonstrate higher compliance, accuracy, utilization, acceptability, feasibility, and validity in migraine feature tracking compared to traditional paper-based migraine diaries among Hong Kong women with migraine. Participants will use different tools (AI-empowered voice-interactive chatbot or paper migraine diary) for migraine tracking. Participants will be randomly allocated to one of two intervention sequences: (1) AI-empowered voice-interactive chatbot followed by paper migraine diary, or (2) paper migraine diary followed by AI-empowered voice-interactive chatbot. The study will consist of two intervention periods, each lasting one month, with a 1:1 allocation ratio.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2025
CompletedFirst Posted
Study publicly available on registry
April 10, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedDecember 15, 2025
April 1, 2025
4 months
March 10, 2025
December 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
timeliness
Timeliness will be defined as the proportion of migraine episodes recorded within 24 hours of onset. This measure will be derived from the data collected through the chatbot and paper diary.
At the end of each 1-month intervention period
Completeness
Completeness will be defined as the proportion of diary entries with all required migraine-related information fully recorded. This measure will be derived from the data collected through the chatbot and paper diary.
At the end of each 1-month intervention period
Missed episodes
Missed episodes will be defined as the proportion of migraine episodes not recorded; the number of missed episodes in each period will be obtained at the end-of-period questionnaire
At the end of each 1-month intervention period
Accuracy
Accuracy will be defined as the proportion of diary entries in which all required migraine-related fields were recorded correctly. Accuracy will be adjudicated by assessing the consistency between migraine features recorded using the chatbot or paper diary and those reported during end-of-period online interviews with study staff. Discrepancies will be documented; records will be not altered for primary analyses. During these interviews, researchers will summarise the participant's recorded migraine information for that period, regardless of modality, and ask the participant to identify any errors.
At the end of each 1-month intervention period
Secondary Outcomes (5)
Utilization
At the end of each 1-month intervention period
Acceptability
At the end of each 1-month intervention period
Usage
At the end of each 1-month intervention period
Time per recording
At the end of each 1-month intervention period
Validity
At the end of each 1-month intervention period
Study Arms (2)
Sequence 1
EXPERIMENTALAI-empowered voice-interactive chatbot followed by paper migraine diary
Sequence 2
EXPERIMENTALPaper migraine diary followed by AI-empowered voice-interactive chatbot
Interventions
Participants will manually document their migraine experiences on the paper migraine diary, including the date and time of the attack, presence of aura, migraine intensity, accompanying symptoms, triggers, and medication use.
Participants will interact with the chatbot on a daily basis to record their migraine experiences. They will be asked to initiate a conversation with the chatbot whenever they experience a migraine attack and provide the required information, including the date and time of the attack, presence of aura, migraine intensity, accompanying symptoms, triggers, and medication use. The chatbot will engage participants in a conversation to collect these data points and store them securely within the chatbot system.
Eligibility Criteria
You may qualify if:
- Women aged 18 years or older
- Meet diagnostic criteria for migraine according to ICHD-3
- Experiencing at least 2 headache days per month
- Living in Hong Kong
- Fluent in Cantonese
- Owning a smartphone with internet access
- Willing to provide informed consent
You may not qualify if:
- Individuals with severe cognitive impairments or communication difficulties
- Those unable to use a smartphone or the chatbot due to physical or mental limitations
- Using another alternative electronic migraine diary during recruitment or in the past 12 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hong Kong Polytechnic University
Hong Kong, HONG KONG, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yao Jie Xie, PhD
The Hong Kong Polytechnic Univeristy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 10, 2025
First Posted
April 10, 2025
Study Start
July 1, 2025
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
December 15, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share